Endothelial progenitor cells: a primer for vascular surgeons
Dania Magri1, Tiffany T Fancher, Tamara N Fitzgerald
1Department of Surgery, Yale University School of Medicine, New Haven, CT 06519, USA.
Vascular
|December 7, 2007
Summary
Endothelial progenitor cells (EPCs) are crucial for vascular repair. Lower EPC levels indicate worse vascular disease, but EPC therapy shows promise for treating ischemia and improving graft patency.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Vascular Biology
Background:
- Endothelial progenitor cells (EPCs) play a vital role in vascular healing.
- Reduced EPC quantity/function is linked to vascular disease severity and impaired healing.
- EPCs are independent risk factors for atherosclerosis and endothelial dysfunction.
Purpose of the Study:
- To review EPC characterization and regulation.
- To explore the role of EPCs in vascular disease.
- To assess the therapeutic potential of EPCs for peripheral vascular disease.
Main Methods:
- Literature review focusing on EPCs.
- Analysis of EPCs' role in vascular injury and disease.
- Evaluation of EPC therapy for ischemia and graft patency.
Main Results:
- EPCs are key to vascular repair in acute and chronic conditions.
- Low EPC levels correlate with increased vascular disease severity.
- EPC therapy aids healing in cardiac/limb ischemia and graft patency.
Conclusions:
- EPCs are critical for maintaining vascular health and repair.
- EPC dysfunction contributes significantly to cardiovascular disease progression.
- EPC therapy offers a promising strategy for managing severe vascular disease and improving patient outcomes.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...